New Search Search History

Holdings Information

    Chromatin deregulation in cancer / edited by Scott A. Armstrong, Dana-Farber Cancer Institute; Steven Henikoff, Fred Hutchinson Cancer Research Center; Christopher R. Vakoc, Cold Spring Harbor Laboratory.

    • Title:Chromatin deregulation in cancer / edited by Scott A. Armstrong, Dana-Farber Cancer Institute; Steven Henikoff, Fred Hutchinson Cancer Research Center; Christopher R. Vakoc, Cold Spring Harbor Laboratory.
    •    
    • Other Contributors/Collections:Armstrong, Scott A., editor.
      Henikoff, Steve, editor.
      Vakoc, Christopher R., editor.
    • Published/Created:Cold Spring Harbor, New York : Cold Spring Harbor Laboratory Press, 2017.
    • Holdings

       
    • Library of Congress Subjects:Cancer--Genetic aspects.
      Chromosome abnormalities.
      Mutation (Biology)
    • Medical Subjects: Neoplasms--genetics.
    • Description:vii, 382 pages : illustrations ; 27 cm
    • Series:Cold Spring Harbor perspectives in medicine.
    • Summary:"The machinery that controls how DNA is packaged and genes are activated plays an important role in cancer. This book examines the functions of components of this machinery, how they can be dysregulated, and the prospects for targeting them therapeutically. Highlights include: - PRC2 polycomb complex - Therapy- Lysine demethylase inhibitors - Epigenetic mechanisms of therapy resistance and tumor heterogeneity - Long non-coding RNA"-- Provided by publisher.
    • Notes:Includes bibliographical references and index.
    • ISBN:9781621821403 (hardback)
      1621821404 (hardback)
    • Contents:Machine generated contents note: Role of the Polycomb Repressive Complex 2 (PRC2) in Transcriptional Regulation and Cancer / Kristian Helin
      Role of Nuclear Receptor
      Binding SET Domain Family Histone Lysine Methytransferases in Cancer / Jonathan D. Licht
      Mixed-Lineage Leukemia Fusions and Chromatin in Leukemia / Scott A. Armstrong
      Oncogenic Mechanisms of Histone H3 Mutations / Chao Lu
      MLL3/MLL4/COMPASS Family on Epigenetic Regulation of Enhancer Function and Cancer / Ali Shilatifard
      Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer / Gerald R. Crabtree
      DNMT3A in Leukemia / Margaret A. Goodell
      TET2 in Normal and Malignant Hematopoiesis / Ross L. Levine
      Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer / Siavash K. Kurdistani
      Role of Additional Sex Combs-Like Proteins in Cancer / Omar Abdel-Wahab
      SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation / Ian J. Davis
      ATRX and DAXX: Mechanisms and Mutations / Emily Bernstein
      Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer / Alea A. Mills
      Cohesin Mutations in Cancer / Ana Losada
      HDACs and HDAC Inhibitors in Cancer Development and Therapy / Edward Seto
      DNA Hypomethylating Drugs in Cancer Therapy / Patricia Kropf
      Targeting Cancer Cells with BET Bromodomain Inhibitors / Christopher R. Vakoc
      Histone Lysine Demethylase Inhibitors / Yang Shi
      Mechanisms of Nucleosome Dynamics In Vivo / Steven Henikoff
      Nonhistone Lysine Methylation in the Regulation of Cancer Pathways / Or Gozani
      Long Noncoding RNAs: At the Intersection of Cancer and Chromatin Biology / Howard Y. Chang.
    Session Timeout
    New Session